These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36273437)

  • 1. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study.
    Sumbul-Sekerci B; Bilgic B; Pasin O; Emre M; Hanagasi HA
    Dement Geriatr Cogn Disord; 2022; 51(5):386-395. PubMed ID: 36273437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Drugs on Mild Cognitive Impairment in Parkinson's Disease: Evidence from the PACOS Study.
    Cicero CE; Monastero R; Terravecchia C; Donzuso G; Luca A; Baschi R; Caccamo M; Mostile G; Giuliano L; Zappia M; Nicoletti A
    Curr Neuropharmacol; 2022; 20(5):998-1003. PubMed ID: 34951389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
    Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
    Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic Medication Burden in Parkinson's Disease Outpatients.
    Nawaz H; Sargent L; Quilon H; Cloud LJ; Testa CM; Snider JD; Lageman SK; Baron MS; Berman BD; Zimmerman K; Price ET; Mukhopadhyay ND; Barrett MJ
    J Parkinsons Dis; 2022; 12(2):599-606. PubMed ID: 34806617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population -Differences between Four Anticholinergic Scales].
    Kimura T; Kato D; Nishimura T; Van Schyndle J; Uno S; Yoshida M
    Yakugaku Zasshi; 2020; 140(5):701-710. PubMed ID: 32378674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic burden in Parkinson's disease inpatients.
    Lertxundi U; Isla A; Solinis MA; Domingo-Echaburu S; Hernandez R; Peral-Aguirregoitia J; Medrano J
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1271-7. PubMed ID: 26254777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic and sedative medication use in older patients with cognitive concerns.
    Hinkle CE; Davis JD; Arias I; Goldstein A; Daiello L; Margolis SA
    J Am Geriatr Soc; 2024 Sep; 72(9):2792-2799. PubMed ID: 38685717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?
    Yarnall AJ; Lawson RA; Duncan GW; Breen DP; Khoo TK; Brooks D; Barker RA; Taylor JP; Burn DJ
    J Parkinsons Dis; 2015; 5(4):743-7. PubMed ID: 26444094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
    Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergics May Carry Significant Cognitive and Gait Burden in Parkinson's Disease.
    Rajan R; Saini A; Verma B; Choudhary N; Gupta A; Vishnu VY; Bhatia R; Singh MB; Srivastava AK; Srivastava MVP
    Mov Disord Clin Pract; 2020 Oct; 7(7):803-809. PubMed ID: 33043076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study.
    Amoros-Reboredo P; Soy D; Hernandez-Hernandez M; Lens S; Mestres C
    Int J Environ Res Public Health; 2020 May; 17(11):. PubMed ID: 32466526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic Exposure in Elderly Complex Chronic Patients: A Cross-Sectional Study.
    Tristancho-Pérez Á; Villalba-Moreno Á; Santos-Rubio MD; López-Malo MD; Santos-Ramos B; Sánchez-Fidalgo S
    Curr Pharm Des; 2021; 27(40):4186-4194. PubMed ID: 34463225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of anticholinergic drugs on cognition of patients with Parkinson's disease: a cohort study from the Egyptian population.
    Hamed SA; Hadad AFE
    Expert Rev Clin Pharmacol; 2024 Aug; 17(8):743-753. PubMed ID: 38781022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment.
    Sumbul-Sekerci B; Hanagasi HA; Bilgic B; Tufekcioglu Z; Gurvit H; Emre M
    Acta Neurol Belg; 2023 Jun; 123(3):823-829. PubMed ID: 35325434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
    Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
    Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance Between Anticholinergic Burden Scales.
    Naples JG; Marcum ZA; Perera S; Gray SL; Newman AB; Simonsick EM; Yaffe K; Shorr RI; Hanlon JT;
    J Am Geriatr Soc; 2015 Oct; 63(10):2120-4. PubMed ID: 26480974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
    Novella A; Elli C; Ianes A; Pasina L
    Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
    Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
    Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.